Dr. Agarwal's Health Care board notes amalgamation scheme effective Nov 1, 2026
Dr Agarwals Health Care Ltd · Healthcare Services
What the filing says
- NCLT order dated September 30, 2026 sanctioned the Scheme; it becomes effective November 01, 2026, with Appointed Date April 01, 2026
- Transferee authorised share capital rises from 90,00,00,000/- to 110,00,00,000/- after merging the Transferor's ₹20,00,00,000/- reclassified capital
- Record Date is November 18, 2026: 23 Transferee equity shares of ₹1 each for every 2 Transferor equity shares of ₹10 each
Why it's rated notable: The NCLT-sanctioned scheme has a binding effective date and a record date, but the filing states no amount or size for the transferor business or the number of consideration shares, so the level is medium.
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Fixation Of Record Date W.R.T. The Scheme Of Amalgamation Between Dr. Agarwals Eye Hospital Limited And Dr. Agarwals Health Care Limited
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Dr Agarwals Health Care Ltd
- Acquisition / mergerNotableNCLT sanctions merger of Dr. Agarwal's Eye Hospital into Dr. Agarwal's Health Care
Other acquisition / merger filings this fortnight
- Sudarshan Europe B.V. discloses substantial acquisition in Heubach Colorants India Ltd
- Sagility Limited acquires Chirok Health to expand provider-focused services
- Dr. Agarwal’s Eye Hospital Ltd approves Scheme of Amalgamation effective Nov 1, 2026
- Shrem InvIT manager's board approves up to INR 1,046 crore NaBFID term loan
- Kwality Pharmaceuticals acquires 4 acres for manufacturing expansion in Amritsar
- EPL Limited receives no-objection letters from BSE and NSE for Scheme of Amalgamation
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.